| 000 | 01007 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516011715.0 | ||
| 264 | 0 | _c20101221 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWinzer, M | |
| 245 | 0 | 0 |
_aUse of methotrexate in patients with systemic lupus erythematosus and primary Sjögren's syndrome. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_aS156-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAringer, M | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 28 _gno. 5 Suppl 61 _gp. S156-9 |
|
| 999 |
_c20343917 _d20343917 |
||